Bhavesh Shah focused on infusion center challenges, notably staffing shortages that cost Boston Medical Center $20 million annually and strain patient access and nurse-to-patient ratios. To address rising infliximab use and labor demands, Sub Q therapies were proposed to enhance efficiency and reduce costs. Presented at 2025 SPS Puerto Rico.